...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: What's the deal with Zenith?

Thanks in advance for any hints about this.

After watching the RVX AGM I'm scratching my head about this company.  I know the stock isn't exactly easy to access, but why is the value so ridiculously low?  It looks like the drugs are actually working, and there are several pharma's paying Zenith's research costs.  What am I missing? Seems like an excellent risk if the stock can be found, no?

 

3
Jun 22, 2023 07:41AM
6
Jun 22, 2023 02:26PM
3
Jun 23, 2023 01:54AM
1
Jun 23, 2023 02:15AM
3
Jun 23, 2023 10:24AM
5
Jun 24, 2023 08:49AM
Share
New Message
Please login to post a reply